October 17, 2011
MediciNova, Inc. of the US announced on October 14 that it has concluded an agreement with Kissei Pharmaceutical to partially and jointly conduct clinical trials for its beta 2-adrenergic receptor agonist MN-221. Under the terms of the agreement, Kissei will...read more